瀏覽量: 76
- 產(chǎn)品名稱: Research Grade Mirikizumab ( 米吉珠單抗 )
- 產(chǎn)品貨號: CSD00514
- 貨期: 現(xiàn)貨
- 價格與訂購: 2480
- 數(shù)量:
- 規(guī)格: 100μg
- 產(chǎn)品信息
- 如何訂購
貨號(Catalog No.)
CSD00514
通用名INN
Mirikizumab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Mirikizumab是一種人源化IgG4單克隆抗體,靶向結(jié)合IL-23的p19亞基。目前,mirikizumab正開發(fā)用于多種免疫性疾病,包括銀屑病、UC及克羅恩?。–D),其中治療中重度斑塊型銀屑病已處于III期臨床。
別名(Alternative names)
LY-3074828
靶點;物種(Specificity target name;species)
IL23A[Homo sapiens]
種類(Species)
Humanized
受體鑒定(Receptor identification)
IgG4-kappa
CAS
1884201-71-1
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .